Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

Clinical trial NCT05652868 · TERMINATED

Trial details

NCT number: NCT05652868
Sponsor: Mythic Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC NSCLC Stage IV NSCLC Stage IIIB Non-Small Cell Lung Cancer Advanced Non-Small Cell Squamous Lung Cancer Advanced Non-Small Cell Lung Cancer Advanced Non-Small Cell Non-Squamous Lung Cancer

Start date: 2023-03-23
Primary completion: 2025-10-31
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.